Senior insider sale
Chief Scientific Officer at CONTINEUM THERAPEUTICS, INC. — senior position signals high conviction
$51.1K
4.17K shares
What this filing means
LORRAIN DANIEL S. plans to sell 4.17K shares of CONTINEUM THERAPEUTICS, INC. valued at approximately $51.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/23/2025ACC: 0001950047-25-010672
Officer· Chief Scientific Officer
Since Mar 2026
4.17K
Shares to sell
$51.1K
Approx. market value
4.17K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
5/9/2017
4.17KTotal acquired4.17K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/9/2017 | Restricted Stock Units N/A | 4.17K | — |
| Total | 4.17K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
4.17K
Market value
$51.1K
12/23/2025
Total
Units
4.17K
Value
$51.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/23/2025 | 4.17K | $51.1K | NASDAQ | Planned |
| Total | 4.17K | $51.1K | ||